Skip to main content

Advertisement

SpringerLink
Log in

Chronic daily headaches in children

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Chronic daily headache (CDH) is increasingly recognized as a problem in pediatrics and tertiary pediatric headache care. It is estimated that up to 4% of the adult population has CDH. Many of these are chronic migraine (CM). The fraction of the pediatric population with CDH appears to be lower, although the prevalence has not been adequately determined. The simplest definition of CDH is more than 15 headache days per month. In the International Classification of Headache Disorders, Second Edition (ICHD-II), several types of CDH have been identified. These criteria have been contrasted with the Silberstein-Lipton criteria, with revisions suggested. The diagnosis of CDH is further complicated and may be initiated by the overuse of analgesic medications (medication overuse headache) and requires the resolution of this issue before a final diagnosis can be established. In children, most CDH appears to have migraine features, although it may not completely meet the ICHD-II criteria for migraine or CM. Evaluation of CDH needs to include a complete history and physical examination to identify any possibility of the secondary headaches or headaches directly attributed to a secondary cause. Treatment and management involve a multidisciplinary approach, including acute therapy for when the headache severity increases (while avoiding medication overuse), preventative therapy to reduce the frequency and impact of the CDH, and biobehavioral therapy to assist with long-term outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lipton RB, Stewart WF: Prevalence and impact of migraine. Neurol Clin 1997, 15:1–13.

    Article  PubMed  CAS  Google Scholar 

  2. Scher AI, Stewart WF, Liberman J, Lipton RB: Prevalence of frequent headache in a population sample. Headache 1998, 38:497–506.

    Article  PubMed  CAS  Google Scholar 

  3. Castillo J, Muñoz P, Guitera V, Pascual J: Epidemiology of chronic daily headache in the general population. Headache 1999, 39:190–196.

    Article  PubMed  CAS  Google Scholar 

  4. Lanteri-Minet M, Auray JP, El Hasnaoui A, et al.: Prevalence and description of chronic daily headache in the general population in France. Pain 2003, 102:143–149.

    Article  PubMed  Google Scholar 

  5. Sillanpää M, Piekkala P, Kero P: Prevalence of headache at preschool age in an unselected child population. Cephalalgia 1991, 11:239–242.

    Article  PubMed  Google Scholar 

  6. Abu-Arafeh I, Russell G: Prevalence of headache and migraine in schoolchildren. BMJ 1994, 309:765–769.

    Google Scholar 

  7. Wang SJ, Fuh JL, Lu SR, Juang KD: Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 2006, 66:193–197.

    Article  PubMed  Google Scholar 

  8. Raieli V, Eliseo M, Pandol. E, et al.: Recurrent and chronic headaches in children below 6 years of age. J Headache Pain 2005, 6:135–142.

    Article  PubMed  Google Scholar 

  9. Powers SW, Patton SR, Hommel KA, Hershey AD: Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. Pediatrics 2003, 112:e1-e5.

    Article  PubMed  Google Scholar 

  10. Osterhaus JT, Townsend RJ, Gandek B, Ware JE Jr: Measuring the functional status and well-being of patients with migraine headache. Headache 1994, 34:337–343.

    Article  PubMed  CAS  Google Scholar 

  11. Stewart WF, Lipton RB, Kolodner K, et al.: Reliability of the migraine disability assessment score in a population-based sample of headache suffers. Cephalalgia 1999, 19:107–114.

    Article  PubMed  CAS  Google Scholar 

  12. Stewart WF, Lipton RB, Simon D, et al.: Validity of an illness severity measure for headache in a population sample of migraine sufferers. Pain 1999, 79:291–301.

    Article  PubMed  CAS  Google Scholar 

  13. Stewart WF, Lipton RB, Kolodner KB, et al.: Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 2000, 88:41–52.

    Article  PubMed  CAS  Google Scholar 

  14. Holmes WF, MacGregor EA, Sawyer JPC, Lipton RB: Information about migraine disability influences physicians’ perceptions of illness severity and treatment needs. Headache 2001, 41:343–350.

    Article  PubMed  CAS  Google Scholar 

  15. Lipton RB, Silberstein SD: The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology 2001, 56(Suppl 1):S35-S42.

    PubMed  CAS  Google Scholar 

  16. Hershey AD, Powers SW, Vockell AL, et al.: PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology 2001, 57:2034–2039.

    PubMed  CAS  Google Scholar 

  17. Hershey AD, Powers SW, Vockell AL, et al.: Development of a patient-based grading scale for PedMIDAS. Cephalalgia 2004, 24:844–849.

    Article  PubMed  CAS  Google Scholar 

  18. Lipton RB, Stewart WF, Scher AI: Epidemiology and economic impact of migraine. Curr Med Res Opin 2001, 17(Suppl 1):s4-s12.

    Article  PubMed  Google Scholar 

  19. Edmeads J, Mackell JA: The economic impact of migraine: an analysis of direct and indirect costs. Headache 2002, 42:501–509.

    Article  PubMed  Google Scholar 

  20. Guidelines for controlled trials of drugs in migraine: first edition. International Headache Society Committee on Clinical Trials in Migraine. Cephalalgia 1991, 11:1–12.

  21. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. Cephalagia 2004, 24(Suppl 1):1–160. This is the latest set of criteria established by the IHS and is the basis for research in headache and CDH.

  22. Silberstein SD, Lipton RB, Solomon S, Mathew NT: Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994, 34:1–7.

    Article  Google Scholar 

  23. Silberstein SD, Lipton RB, Sliwinski M: Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996, 47:871–875. S-L criteria for CDH. This article establishes basic criteria and tests those criteria for a variety of CDH subtypes.

    PubMed  CAS  Google Scholar 

  24. Bigal ME, Tepper SJ, Sheftell FD, et al.: Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache 2004, 44:684–691. This compares and contrasts the S-L criteria with the ICHD-II in the diagnosis of CDH.

    Article  PubMed  Google Scholar 

  25. Hershey AD, Powers SW, Bentti AL, et al.: Characterization of chronic daily headaches in children in a multidisciplinary headache center. Neurology 2001, 56:1032–1037.

    PubMed  CAS  Google Scholar 

  26. Koenig MA, Gladstein J, McCarter RJ, et al.: Chronic daily headache in children and adolescents presenting to tertiary headache clinics. Headache 2002, 42:491–500.

    Article  PubMed  Google Scholar 

  27. Bigal ME, Rapoport AM, Tepper SJ, et al.: The Classification of chronic daily headache in adolescents--a comparison between the second edition of the international Classification of headache disorders and alternative diagnostic criteria. Headache 2005, 45:582–589.

    Article  PubMed  Google Scholar 

  28. Bigal ME, Tepper SJ, Sheftell FD, et al.: Field testing alternative criteria for chronic migraine. Cephalalgia 2006, 26:477–482.

    Article  PubMed  CAS  Google Scholar 

  29. Olesen J, Bousser MG, Diener HC, et al.: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006, 26:742–746. This is the suggested revision to the use of the ICHD-II criteria for CDH.

    Article  PubMed  CAS  Google Scholar 

  30. Wang SJ, Fuh JL, Lu SR, et al.: Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 2000, 54:314–319.

    PubMed  CAS  Google Scholar 

  31. Vasconcellos E, Pina-Garza JE, Millan EJ, Warner JS: Analgesic rebound headache in children and adolescents. J Child Neurol 1998, 13:443–447.

    PubMed  CAS  Google Scholar 

  32. Meskunas CA, Tepper SJ, Rapoport AM, et al.: Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 2006, 46:766–772.

    Article  PubMed  Google Scholar 

  33. Kossoff EH, Mankad DN: Medication-overuse headache in children: is initial preventive therapy necessary? J Child Neurol 2006, 21:45–48.

    PubMed  Google Scholar 

  34. Gladstein J, Holden EW: Chronic daily headache in children and adolescents: a 2-year prospective study. Headache 1996, 36:349–351.

    Article  PubMed  CAS  Google Scholar 

  35. Tang Y, Gilbert DL, Glauser TA, et al.: Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol 2005, 62:210–215.

    Article  PubMed  Google Scholar 

  36. Srikiatkhachorn A, Tarasub N, Govitrapong P: Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 2000, 40:343–350.

    Article  PubMed  CAS  Google Scholar 

  37. Welch KM, Nagesh V, Aurora SK, Gelman N: Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001, 41:629–637.

    Article  PubMed  CAS  Google Scholar 

  38. Goadsby PJ: Is migraine a progressive disorder? Considering the clinical implications of new research data on migraine and brain lesions. Med J Aust 2005, 182:103–104.

    PubMed  Google Scholar 

  39. Lipton RB, Pan J: Is migraine a progressive brain disease? JAMA 2004, 291:493–494.

    Article  PubMed  CAS  Google Scholar 

  40. Hershey AD, Powers SW, Kabbouche MA, et al.: Genomic profiles in patients with chronic migraine: responders vs. non-responders. Cephalalgia 2005, 25:852–853.

    Google Scholar 

  41. Rothrock JF: Management of chronic daily headache utilizing a uniform treatment pathway. Headache 1999, 39:650–653.

    Article  PubMed  CAS  Google Scholar 

  42. Dodick DW: Clinical practice: chronic daily headache. N Engl J Med 2006, 354:158–165. General review of CDH that covers practical diagnosis and treatment in adults.

    Article  PubMed  CAS  Google Scholar 

  43. Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P: Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology 1997, 48:103–107.

    PubMed  Google Scholar 

  44. Lewis D, Kellstein D, Dahl G, et al.: Children’s ibuprofen suspension for pediatric migraine. Ann Neurol 2001, 50(Suppl 1):S93.

    Google Scholar 

  45. Linton-Dahlöf P, Linde M, Dahlöf C: Withdrawl therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 2000, 20:658–662.

    Article  PubMed  Google Scholar 

  46. Kabbouche MA, Vockell AL, LeCates SL, et al.: Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics 2001, 107:E62.

    Article  PubMed  CAS  Google Scholar 

  47. Linder SL: Treatment of childhood headache with dihydroergotamine mesylate. Headache 1994, 34:578–580.

    Article  PubMed  CAS  Google Scholar 

  48. Lipton RB, Stewart WF, Cady R, et al.: Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache 2000, 40:783–791.

    Article  PubMed  CAS  Google Scholar 

  49. Cady RC, Ryan R, Jhingran P, et al.: Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Arch Intern Med 1998, 9:1013–1018.

    Article  Google Scholar 

  50. Winner P, Rothner D, Saper J, et al.: A randomized, doubleblind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 2000, 106:989–997.

    Article  PubMed  CAS  Google Scholar 

  51. Winner P, Saper JR, Nett R, et al.: Sumatriptan nasal spray in the acute treatment of migraine in adolescent migraineurs. Headache 1999, 39:386.

    Google Scholar 

  52. Ueberall MA, Wenzel D: Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 1999, 52:1507–1510.

    PubMed  CAS  Google Scholar 

  53. Hershey AD, Powers SW, LeCates S, Bentti AL: Effectiveness of nasal sumatriptan in 5-to 12-year-old children. Headache 2001, 41:693–697.

    Article  PubMed  CAS  Google Scholar 

  54. MacDonald JT: Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 1994, 34:581–582.

    Article  PubMed  CAS  Google Scholar 

  55. Hämäläinen ML, Hoppu K, Santavuori P: Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Neurology 1997, 48:1100–1103.

    PubMed  Google Scholar 

  56. Linder SL: Subcutaneous sumatriptan in the clinical setting: the first fifty consecutive patients with acute migraine in a pediatric neurology office practice. Headache 1995, 35:291–292.

    Google Scholar 

  57. Redillas C, Solomon S: Prophylactic pharmacological treatment of chronic daily headache. Headache 2000, 40:83–102.

    Article  PubMed  CAS  Google Scholar 

  58. Hershey AD, Powers SW, Bentti AL, Degrauw TJ: Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000, 40:539–549.

    Article  PubMed  CAS  Google Scholar 

  59. Landy S, McGinnis J, Curlin D, Laizure C: Selective serotonin reuptake inhibitors for migraine prophylaxis. Headache 1999, 39:28–32.

    Article  PubMed  CAS  Google Scholar 

  60. Mathew NT, Saper JR, Silberstein SD, et al.: Migraine prophylaxis with divalproex. Arch Neurol 1995, 52:281–286.

    PubMed  CAS  Google Scholar 

  61. Freitag F, Diamond S, Diamond ML, Urban GJ: Divalproex in the long-term treatment of chronic daily headache. Headache 2001, 41:271–288.

    Article  PubMed  CAS  Google Scholar 

  62. Freitag F, Collins SD, Carlson HA, et al.: A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 2002, 58:1652–1659.

    PubMed  CAS  Google Scholar 

  63. Caruso JM, Brown WD, Exil G, Gascon GG: The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 2000, 40:672–676.

    Article  PubMed  CAS  Google Scholar 

  64. Mathew NT, Rapoport A, Saper J, et al.: Efficacy of gabapentin in migraine prophylaxis. Headache 2001, 41:119–228.

    Article  PubMed  CAS  Google Scholar 

  65. Brandes JL, Saper JR, Diamond M, et al.: Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004, 291:965–973.

    Article  PubMed  CAS  Google Scholar 

  66. Winner P, Pearlman E, Linder S, et al.: Topiramate for the prevention of migraines in children and adolescents: a randomized, double-blind, placebo-controlled trial. Headache 2004, 44:481.

    Google Scholar 

  67. Winner P, Pearlman EM, Linder SL, et al.: Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005, 45:1304–1312.

    Article  PubMed  Google Scholar 

  68. Silvestrini M, Bartolini M, Coccia M, et al.: Topiramate in the treatment of chronic migraine. Cephalalgia 2003, 23:820–824.

    Article  PubMed  CAS  Google Scholar 

  69. Bille B, Ludvigsson J, Sanner G: Prophylaxis of migraine in children. Headache 1977, 17:61–63.

    Article  PubMed  CAS  Google Scholar 

  70. Ludvigsson J: Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 1974, 50:109–115.

    Article  PubMed  CAS  Google Scholar 

  71. Silberstein SD, Stark SR, Lucas SM, et al.: Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc 2005, 80:1126–1137.

    Article  PubMed  CAS  Google Scholar 

  72. Solomon S: Regarding botulinum toxin for the prophylaxis of chronic daily headache. Headache 2006, 46:528; author reply 529–530.

    Article  PubMed  Google Scholar 

  73. Mathew NT, Dodick DW: Botulinum toxin type a (Botox) for prophylactic treatment of chronic daily headache: a response. Headache 2006, 46:529–530.

    Article  Google Scholar 

  74. Dodick DW, Mauskop A, Elkind AH, et al.: Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 2005, 45:315–424.

    Article  PubMed  Google Scholar 

  75. Mathew NT, Frishberg BM, Gawel M, et al.: Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache 2005, 45:293–307.

    Article  PubMed  Google Scholar 

  76. Kabbouche MA, Hershey AD, Powers SW, et al.: Botulinum toxin A in the treatment of migraine headache in children. Headache 2005, 45:786.

    Article  Google Scholar 

  77. Duckro PN, Cantwell-Simmons E: A review of studies evaluating biofeedback and relaxation training in the management of pediatric headache. Headache 1989, 29:428–433.

    Article  PubMed  CAS  Google Scholar 

  78. Powers SW, Hershey AD: Biofeedback for childhood migraine. In Current Management in Child Neurology, edn 2. Edited by Maria BL. Hamilton, Ontario: BC Decker Inc.; 2002:83–85.

    Google Scholar 

  79. Powers SW, Mitchell MJ, Byars KC, et al.: A pilot study of one-session biofeedback training in pediatric headache. Neurology 2001, 56:133.

    PubMed  CAS  Google Scholar 

  80. Juant KD, Wang SJ, Fuh JL, et al.: Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000, 40:818–823.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Headache Center, Division of Neurology, Cincinnati Children’s Hospital, 3333 Burnet Avenue, MLC 2015, 45229, Cincinnati, OH, USA

    Andrew D. Hershey MD, PhD (Director)

Authors
  1. Andrew D. Hershey MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marielle A. Kabbouche MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Scott W. Powers PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew D. Hershey MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hershey, A.D., Kabbouche, M.A. & Powers, S.W. Chronic daily headaches in children. Current Science Inc 10, 370–376 (2006). https://doi.org/10.1007/s11916-006-0062-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-006-0062-7

Keywords

Search

Navigation